Please assess the completion status of the following clinical trial:

Trial Title: Performance Study of an Artificial Nerve Guide (Reaxon® Nerve Guide) to Treat Digital Nerve Lesions

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. males and females between 18 and 65 years of age able to give his/her consent~2. a complete traumatic nerve injury of the common or proper digital nerve in the hand~3. a nerve defect of less or equal than 26 mm after release and approximation of the nerve ends and measured when the wrist is in neutral position~4. an injury that could conventionally be treated with implantation of a short nerve graft~5. nerve treatment initiated until 3 months after nerve injury~6. signed informed consent~Exclusion Criteria:~1. known allergy to chitosan and/or polyvinylpyrrolidone (PVP)~2. known impairment / previous diseases of the neural axis or previous lesions of the affected hand (of the digital nerve), which led to permanent sensory or motor restrictions of the hand/finger~3. complete amputation injury~4. known pregnant or breast-feeding females~5. disorders known leading to impaired wound healing (e.g. diabetes mellitus)~6. skin diseases in the wound area~7. impaired blood coagulation or bleeding disorders (e.g. because of regular intake of cumarin such as Marcumar)~8. pathologic blood flow disorders (e.g. Morbus Raynaud)~9. participated in another clinical investigation using an investigational new drug or device within 30 days prior to enrolment into this investigation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Reaxon® Nerve Guide (Type: EXPERIMENTAL): Implantation of Reaxon® Nerve Guide: If the subject is randomized to the Reaxon® Nerve Guide group, the surgeon will implant a Reaxon® Nerve Guide of ≤ 30 mm to bridge a nerve defect of ≤ 26 mm according to the method described in the instructions for use.
- Autologous Nerve Graft (Type: ACTIVE_COMPARATOR): Implantation of an autologous nerve graft: If the subject is randomized to the conventional treatment, the surgeon will repair the nerve by interposing an autologous nerve graft of ≤ 26 mm between the nerve ends.

Based on this trial design, predict the completion outcome and termination type (if applicable).